BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a…
NEW YORK, Aug. 23, 2024 /PRNewswire/ -- The global epedigree software market size is estimated to grow by USD 4.02 billion…
TORONTO, ON / ACCESSWIRE / August 23, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or…
NEW YORK, Aug. 23, 2024 /PRNewswire/ -- The global clinical trial management system (CTMS) market size is estimated to grow by…
Another milestone in ADVI’s growth strategy further accelerates the firm’s mission and vision to be the leading life sciences commercialization…
CHICAGO, Aug. 23, 2024 /PRNewswire/ -- The global Laboratory Informatics Market is valued at an estimated USD 5.3 billion in…
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…
LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing…
VANCOUVER, Washington, Aug. 23, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab,…
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial…